Net loss of Aspira Pathlab & Diagnostics reported to Rs 0.74 crore in the quarter ended December 2023 as against net profit of Rs 0.44 crore during the previous quarter ended December 2022. Sales declined 20.82% to Rs 3.46 crore in the quarter ended December 2023 as against Rs 4.37 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales3.464.37 -21 OPM %-10.6918.54 - PBDT-0.360.83 PL PBT-0.740.44 PL NP-0.740.44 PL Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics has revised the meeting of the Board of Directors which was scheduled to be held on 10 February 2024. The meeting will now be held on a later date.Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 10 February 2024.Powered by Capital Market - Live News

Net loss of Aspira Pathlab & Diagnostics reported to Rs 0.71 crore in the quarter ended September 2023 as against net profit of Rs 0.02 crore during the previous quarter ended September 2022. Sales declined 10.51% to Rs 3.32 crore in the quarter ended September 2023 as against Rs 3.71 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales3.323.71 -11 OPM %-10.8412.40 - PBDT-0.320.42 PL PBT-0.710.02 PL NP-0.710.02 PL Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2023.Powered by Capital Market - Live News